29371 | 29371 | Diabetes Mellitus After Intensive Care Admission | Recruiting | No Results Available | Stress Hyperglycemia|Diabetes Mellitus | Other: Oral glucose tolerance test | https://ClinicalTrials.gov/show/NCT02180555 |
29372 | 29372 | Atrial Fibrillation and Premature Atrial Complexes in Patients With Ischemic Stroke. | Active, not recruiting | No Results Available | Stroke|Atrial Fibrillation|Premature Atrial Complexes | | https://ClinicalTrials.gov/show/NCT02180542 |
29373 | 29373 | The Effects of Methylphenidate on the Cognitive Function of Older People With Mild Cognitive Impairment | Not yet recruiting | No Results Available | Mild Cognitive Impairment (MCI) | Drug: Methylphenidate|Drug: Placebo | https://ClinicalTrials.gov/show/NCT02180529 |
29374 | 29374 | Safety and Efficacy of Meloxicam Compared to Other Nonsteroidal Antiinflammatory Drugs (NSAIDs) in an Observational Cohort Study of Patients With Rheumatoid Arthritis, Osteoarthritis, Lumbago, Scapulohumeral Periarthritis, Neck, Shoulder and Arm Syndrome | Completed | No Results Available | Arthritis, Rheumatoid | Drug: Meloxicam|Drug: Other Non Steroidal Anti-Inflammatory Drugs (NSAIDs) except etodolac | https://ClinicalTrials.gov/show/NCT02180516 |
29375 | 29375 | Relative Bioavailability of 1 mg and 10 mg BI 1356 BS as Powder in the Bottle (PIB) to 1 mg and 10 mg BI 1356 BS as Tablets as Single Oral Administration in Healthy Male Volunteers Including the Influence of Food on the Bioavailability of 10 mg BI 1356 BS | Completed | No Results Available | Healthy | Drug: BI 1356 BS PIB - low dose|Drug: BI 1356 BS tablet - low dose|Drug: BI 1356 BS PIB - high dose|Drug: BI 1356 BS tablet - high dose|Drug: BI 1356 BS tablet - high dose with food | https://ClinicalTrials.gov/show/NCT02180503 |
29376 | 29376 | Bioequivalence Study of UHAC 62 XX Tablets Compared With Capsules in Healthy Volunteers | Completed | No Results Available | Healthy | Drug: UHAC 62 XX tablet|Drug: UHAC 62 XX capsule | https://ClinicalTrials.gov/show/NCT02180490 |
29377 | 29377 | Preliminary Bioequivalence Study of UHAC 62 XX Tablets Compared With a Capsule Formulation in Healthy Male Volunteers | Completed | No Results Available | Healthy | Drug: UHAC 62 XX - TF1 tablet|Drug: UHAC 62 XX - TF2 tablet|Drug: UHAC 62 XX - capsules | https://ClinicalTrials.gov/show/NCT02180477 |
29378 | 29378 | A Intra-individual Comparison to Investigate the Efficacy and the Safety of LAS41004 Formulation in Mild to Moderate Psoriasis | Completed | No Results Available | Psoriasis | Drug: LAS41004|Drug: control | https://ClinicalTrials.gov/show/NCT02180464 |
29379 | 29379 | Observational Study to Investigate the Melatonin and Cortisol Circadian Rhythms of Individuals With Smith-Magenis Syndrome (SMS) | Recruiting | No Results Available | Smith Magenis Syndrome | | https://ClinicalTrials.gov/show/NCT02180451 |
29380 | 29380 | An Open Label Trial of Stribild for Antiretroviral (ARV)-naïve HIV-2 Infected Adults in Dakar, Senegal | Recruiting | No Results Available | HIV-2 Infection | Drug: Stribild (Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF) 1 tablet daily X 48 weeks | https://ClinicalTrials.gov/show/NCT02180438 |
29381 | 29381 | The Lipid Profile of the Skin Surface in Acne | Active, not recruiting | No Results Available | Acne | Drug: Tretinoin or Adapalene|Drug: Isotretinoin | https://ClinicalTrials.gov/show/NCT02180425 |
29382 | 29382 | Controlled Trial of Panhematin in Treatment of Acute Attacks of Porphyria | Recruiting | No Results Available | Acute Porphyrias | Biological: Panhematin|Other: Placebo | https://ClinicalTrials.gov/show/NCT02180412 |
29383 | 29383 | Serial Measurement of Capillary Blood Lactate in the Management of Sepsis | Not yet recruiting | No Results Available | Sepsis | | https://ClinicalTrials.gov/show/NCT02180399 |
29384 | 29384 | Effect of PlayStation Distraction in the Dental Setting | Recruiting | No Results Available | Global Behaviour Measure | Behavioral: Patients will play a video game with Rimax® multimedia eyeglasses that occlude the environment partially during the second treatment visit. | https://ClinicalTrials.gov/show/NCT02180386 |
29385 | 29385 | PREDICT-PVI Understanding Peripheral Restenosis: Genomic and Proteomic Determinants of Vascular Intervention | Enrolling by invitation | No Results Available | Peripheral Artery Disease | | https://ClinicalTrials.gov/show/NCT02180373 |
29386 | 29386 | Capoeira Training and Flexibility | Completed | No Results Available | Flexibility|Range of Motion | Other: Capoeira training group | https://ClinicalTrials.gov/show/NCT02180360 |
29387 | 29387 | Contact Lenses and Myopia | Recruiting | No Results Available | Myopia | Device: Contact lenses | https://ClinicalTrials.gov/show/NCT02180347 |
29388 | 29388 | The Effect of Combination of Mosapride and DPP-4 Inhibitor on Plasma Concentration of Incretin Hormones | Not yet recruiting | No Results Available | Diabetes Mellitus, Type 2 | Drug: Mosapride citrate|Drug: Linagliptin|Drug: Acetaminophen (paracetamol) | https://ClinicalTrials.gov/show/NCT02180334 |
29389 | 29389 | Effect of Tranexamic Acid Based on Pharmacokinetics in Pediatric Patients Undergoing Craniosynostosis Surgery: Randomized Controlled Trial | Recruiting | No Results Available | Craniosynostosis Patients Undergoing Distraction Osteotomy | Drug: Tranexamic Acid|Drug: normal saline | https://ClinicalTrials.gov/show/NCT02180321 |
29390 | 29390 | Lymph Node Assessment Using Simultaneous 18F-FDG-PET and MRI | Recruiting | No Results Available | Head and Neck Cancer | Device: PET/MRI | https://ClinicalTrials.gov/show/NCT02180308 |
29391 | 29391 | A Lot-to-Lot Consistency Study to Evaluate Safety, Tolerability, and Immunogenicity of Inactivated Varicella Zoster Virus (VZV) Vaccine in Healthy Adults (V212-014) | Withdrawn | No Results Available | Herpes Zoster | Biological: V212 Lot 1|Biological: V212 Lot 2|Biological: V212 Lot 3 | https://ClinicalTrials.gov/show/NCT02180295 |
29392 | 29392 | Impact of the M22-IPL Acne Filter on Acne Vulgaris | Recruiting | No Results Available | Acne | Device: M22-IPL | https://ClinicalTrials.gov/show/NCT02180282 |
29393 | 29393 | A Safety, Tolerability and Pharmacokinetics Study of JNJ-54861911 in Healthy Japanese Male Participants | Completed | No Results Available | Healthy | Drug: JNJ-54861911 (25 mg)|Drug: JNJ-54861911 (50 mg)|Drug: JNJ-54861911 (100 mg)|Drug: Placebo | https://ClinicalTrials.gov/show/NCT02180269 |
29394 | 29394 | Effect of Endometrial Scratching on Assisted Reproduction Outcomes: a Randomized Controlled Trial | Enrolling by invitation | No Results Available | #NAME? | Procedure: Endometrial Scratching | https://ClinicalTrials.gov/show/NCT02180256 |
29395 | 29395 | CAM in Veterans With Gulf War Illnesses | Not yet recruiting | No Results Available | Gulf War Veterans' Illness | Behavioral: Yoga/Acupuncture|Other: Gulf War Health Education | https://ClinicalTrials.gov/show/NCT02180243 |
29396 | 29396 | Immediate Function of NobelSpeedy Shorty and Brånemark System® Mk III Shorty Implants in Daily Use | Active, not recruiting | No Results Available | Patients With Good Quality Bone, Missing at Least One Tooth in the Upper or Lower Jaw. | Device: NobelSpeedy Shorty implant|Device: Brånemark System Mk III Shorty implants | https://ClinicalTrials.gov/show/NCT02180230 |
29397 | 29397 | Safety and Efficacy of LCI699 for the Treatment of Patients With Cushing's Disease | Recruiting | No Results Available | Cushing's Disease | Drug: LCI699 | https://ClinicalTrials.gov/show/NCT02180217 |
29398 | 29398 | Tenecteplase Versus Alteplase in Ischemic Stroke Management (TALISMAN) | Withdrawn | No Results Available | Ischemic Stroke | Drug: Tenecteplase|Drug: Alteplase | https://ClinicalTrials.gov/show/NCT02180204 |
29399 | 29399 | Gut Microbiota in Obesity and Diabetes | Completed | No Results Available | Obesity|Type 2 Diabetes Mellitus | Other: Comparison of the gut microbiota composition | https://ClinicalTrials.gov/show/NCT02180191 |
29400 | 29400 | Mainz Intracoronary Database. The Coronary Slow-flow and Microvascular Diseases Registery | Recruiting | No Results Available | Coronary Artery Disease|Microvascular Dysfunction | Other: observational only- no intervention | https://ClinicalTrials.gov/show/NCT02180178 |